Excited to see this paper out from my former team at Providence Health Center in Santa Monica. Very good work and congratulations to All ๐๐๐ช๐ปhttps://t.co/iiTOtZfwSl
Congratulations to Dr Kim Margolin, for this very much deserved award. Thank you, Dr Margolin for all what you have done for patients and for the immunotherapy field.
Proud and honored to speak at the 2nd Melanoma Symposium in Santa Monica this coming Saturday, April 29th 2023- Register below and plan to attend! Melanoma Symposium - Saint Johnโs Cancer Institute (https://t.co/7KTAi7tKrs)
Next generation immuno-oncology strategies: Unleashing NK cells activity, is now available online. Thanks to the team for this solid work and happy reading. https://t.co/9E924Of3b7
PRACTICE CHANGING news in #uveal#melanoma. @FDAOncology approved tebentafusp for advanced uveal melanoma. This is huge- first drug to show OS benefit in this patient population! Thanks to the patients who participated in this trial and congrats to the investigators! @OncoAlert
From the Nov. issue: Resistance to durvalumab and durvalumab plus tremelimumab is associated with functional #STK11 mutations in non-small-cell #lungcancer patients and is reversed by STAT3 knockdown. https://t.co/tVWXlYsK7X
@nabendu71@MLAscierto et. al @AstraZeneca
Congrats to @Immunocore for @NEJM publication Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. Proud to be part of this program and its success for our patients
#clinicaltrials@angelesclinic
https://t.co/jqg525hZwk
Can't escape T cell exhaustion in the latest @NatImmunol, with a triptych of papers from: @DebattamaSen@EJohnWherry, Georg Lauer and a great N&V explainer from @Hazemghoneim11
https://t.co/hyT8nc1WSq [1/n]
One Post- Doctoral Fellowship and one Flow Cytometry Specialist position are immediately available at St Johnโs Cancer Institute. Join my team to support the advancement of Immunology, Cancer Immunotherapy, Biomarker Discovery #immunotherapy,#immunology,#jobopening,
One post-doctoral fellowship and one flow cytometry position are immediately available in the Translational Cancer #Immunology Unit, Providence St Johnโs Cancer Institute in Santa Monica, California. If interested, send an email to [email protected]